Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Dirck L. Dillehay"'
Autor:
Alfred H. Merrill, Dennis C. Liotta, Dirck L. Dillehay, M. Cameron Sullards, Sarah T. Pruett, Jeremy C. Allegood, Suzanne G. Mays, Harsha Ramaraju, Qiong Peng, Anatoliy Bushnev, Holly Symolon
Supplementary Figures 1-6 from Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and In vivo Models for Intestinal and Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec397518129adf12f4a11a6f645182a
https://doi.org/10.1158/1535-7163.22502085
https://doi.org/10.1158/1535-7163.22502085
Autor:
Alfred H. Merrill, Dennis C. Liotta, Dirck L. Dillehay, M. Cameron Sullards, Sarah T. Pruett, Jeremy C. Allegood, Suzanne G. Mays, Harsha Ramaraju, Qiong Peng, Anatoliy Bushnev, Holly Symolon
Supplementary Methods and Results from Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and In vivo Models for Intestinal and Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53635582c1aab65452d6dd31168e961c
https://doi.org/10.1158/1535-7163.22502079
https://doi.org/10.1158/1535-7163.22502079
Autor:
Alfred H. Merrill, Dennis C. Liotta, Dirck L. Dillehay, M. Cameron Sullards, Sarah T. Pruett, Jeremy C. Allegood, Suzanne G. Mays, Harsha Ramaraju, Qiong Peng, Anatoliy Bushnev, Holly Symolon
Supplementary Material from Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and In vivo Models for Intestinal and Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43de3ce1c522b807c7c6aca2d1619f79
https://doi.org/10.1158/1535-7163.22502082.v1
https://doi.org/10.1158/1535-7163.22502082.v1
Autor:
Robert L. Engler, Weiwei Shi, Dirck L. Dillehay, Gabor M. Rubanyi, L. Susan Schmarkey, C. Collin Bone, Marah E. Condit, Rong Jiang, Jakob Vinten-Johansen
Publikováno v:
Human Gene Therapy Methods. 23:204-212
Efficiency of intracoronary (IC) adenoviral vector transfection is impaired by the vascular endothelium. Ischemia and substances that increase vascular permeability (sodium nitroprusside, nitroglycerin) may augment adenoviral vector transfection effi
Autor:
Lieping Chen, Liguo Niu, Trent Spencer, Benyue Zhang, Simona Strahotin, David R. Archer, Becker Hewes, Robert S. Mittler, Byoung S. Kwon, Anthony T. Vella, Dirck L. Dillehay, Yuanyuan Zhang
Publikováno v:
The Journal of Immunology. 178:4194-4213
CD137-mediated signals costimulate T cells and protect them from activation-induced apoptosis; they induce curative antitumor immunity and enhance antiviral immune responses in mice. In contrast, anti-CD137 agonistic mAbs can suppress T-dependent hum
Publikováno v:
The Journal of Nutrition. 134:1157-1161
Dietary supplementation with milk sphingolipids inhibits colon tumorigenesis in CF1 mice treated with a colon carcinogen [1,2-dimethylhydrazine (DMH)] and in multiple intestinal neoplasia (Min) mice, which develop intestinal tumors spontaneously. Pla
Autor:
Pingping Fu, Dirck L. Dillehay, Mei-Whey H. Wu, Cheng-Feng Chiang, Shur-Wern Wang, Guang-Jer Wu, Qiong Peng
Publikováno v:
Gene. 327:201-213
MUC18, a cell adhesion molecule (CAM), has been reported to be a diagnostic marker for the early detection of the metastatic potential of prostate cancers as well as implicated to be an important determinant for mediating the tumorigenesis and metast
Autor:
Eva M. Schmelz, Lori A. Lemonnier, Dirck L. Dillehay, Judith Abrams, Michael J. Vespremi, Ernest Brody
Publikováno v:
Archives of Biochemistry and Biophysics. 419:129-138
Intestinal cells are regularly exposed to sphingolipid metabolites, i.e., ceramide and sphingoid bases, after hydrolysis of complex sphingolipids from the diet. These metabolites are known regulators of cell growth, differentiation, and death. Non-ph
Autor:
Alfred H. Merrill, David S. Menaldino, Dirck L. Dillehay, M. Cameron Sullards, Qiong Peng, Aiming Sun, Dennis C. Liotta, Anatoliy S. Bushnev, Jeremy C. Allegood, Elaine Wang, Sarah Trotman-Pruett, Holly Symolon, Kena Desai
Publikováno v:
Pharmacological Research. 47:373-381
The sphingoid base backbones of sphingolipids (sphingosines, sphinganines, 4-hydroxysphinganines and others) are highly bioactive species directly and-in most cases-as their metabolites, the N-acyl-sphingoid bases (ceramides) and sphingoid base 1-pho